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Abstract
Classical Swine Fever (CSF) is considered an endemic disease in European wild boar populations. In view of the high
economic impact of the introduction of the virus into domestic pig units, huge efforts are invested in the preventive
control of CSF in wild boar populations. Recent European Community guidelines favour oral mass vaccination against
CSF in wild boar populations. The guidelines are explicit on the temporal structure of the vaccination protocol, but little
is known about the efficacy of different spatial application schemes, or how they relate to outbreak dynamics.
We use a spatially explicit, individual-based wild boar model that represents the ecology of the hosts and the
epidemiology of CSF, both on a regional scale and on the level of individual course of infection. We simulate
adaptive spatial vaccination schemes accounting for the acute spread of an outbreak while using the temporal
vaccination protocol proposed in the Community guidelines.
Vaccination was found to be beneficial in a wide range of scenarios. We show that the short-term proactive
component of a vaccination strategy is not only as decisive as short-term continuity, but also that it can
outcompete alternative practices while being practically feasible. Furthermore, we show that under certain virus-
host conditions vaccination might actually contribute to disease persistence in local populations.
Introduction
Disease outbreaks in wildlife populations often have
huge economic consequences for the livestock industry
[1,2] or pose an enormous risk to public health [3-6].
Managing diseases in wildlife populations is therefore of
paramount importance [7]. Oral mass treatment is one
method of choice in wildlife disease control [8-12]. Mass
vaccination, for example, has largely succeeded in eradi-
cating rabies in Central Europe [13-15]. Although the
success of large-scale control efforts has been demon-
strated repeatedly in the field [16-20], other studies
show that wildlife diseases persisted for decades despite
huge control efforts [21,22].
In contingency strategy planning, research has very
much focused on the level of treatment coverage
required for herd-immunity or disease fade-out [23-29]
or on temporal aspects such as the timing of campaigns
in relation to seasonal reproduction in wildlife
[20,29-34]. Particularly in the design of wildlife mass
treatment programmes spatial aspects may play an
important role in relation to species’ dispersal abilities,
spatial heterogeneity and spatio-temporal disease spread
[35-37]. Integrating existing knowledge of the host’s
ecology and behaviour into application strategies is cru-
cial for optimising the control of wildlife diseases [38].
Classical Swine Fever (CSF) in wild boar populations is
a prominent example. In recent years, the virus circulated
in wild boar in several European countries. Having
entered livestock, it resulted in severe economic losses
both for individual farmers and for national economies
[1,39,40]. Wild boar are considered a virus reservoir and
t h em a i ns o u r c eo fi n f e c t i o nf o rd o m e s t i cp i gf a r m s
through direct contact and swill feeding [40]. Enormous
effort has been invested in oral vaccination campaigns,
hygiene and hunting measures during outbreaks in sev-
eral countries. However, the effects of these measures on
disease dynamics are not always fully understood [29].
Hunting, particularly of juvenile boars, was considered an
effective measure against CSF by reducing the densities
of susceptible hosts, but later turned out to be a factor
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pensatory breeding and boar dispersal [18,29,41-43].
Current research on oral mass vaccination using hand-
distributed baits at feeding sites still shows contradicting
results [20,29,44]. In some cases oral mass vaccination was
shown to eradicate the infection [18,20,45], while in other
cases mass vaccination did not lead to disease extinction
[21,22]. This difference is attributed to the highly dynamic
host population over space and time [46,47], the involve-
ment of virus strains with different virulence [48] and the
variability of the disease outcome between infected indivi-
duals [49,50]. As a consequence, there is still a debate
about the most reasonable control aims of mass vaccina-
tion in wild boar, the usefulness of marker vaccines to
monitor control in the field, or the most plausible spatio-
temporal design for vaccination protocols [29,51]. In this
context, Rossi et al. [20] were able to demonstrate for a
forest area in France that preventive vaccination, i.e. vacci-
nating the unaffected population around an outbreak, is
more effective than treating infected areas only.
The purpose of this study is the systematic investiga-
tion of spatially differentiated baiting regimes with regard
to their efficacy in limiting the spread and survival of the
infection in a wild boar population. The systematic com-
parison of vaccination schemes requires consideration of
large spatial and temporal scales. Moreover, the complex
interaction of host ecology and behaviour, infection
dynamics, variable virulence and control effects limits
potential of empirical experimentation. Process-based
epidemiological modelling can capture biological variabil-
ity and uncertainty with their delicate balance among
potentially counteracting effects [41,52-54]. We use a
validated ecological-epidemiological model and compare
current spatial baiting strategies with alternative schemes.
We show why current baiting schemes have suboptimal
control characteristics and, how control could profit
from orally applicable marker vaccines [41,51]. Moreover,
we specify epidemiological conditions under which artifi-
cial immunisation through oral vaccination can even
facilitate disease persistence.
Materials and methods
Model description
Overview
Our model is based on the approach by Kramer-Schadt et
al. [53] and is implemented in FreePascal/Lazarus. The
individual-based, spatially explicit ecological-epidemiologi-
cal model was parameterised with field data. It is described
according to the ODD protocol (overview, design, details
[55,56]). Submodels are presented where essential for
understanding the model output or where modified from
the literature version. Complete submodel descriptions are
given in the Additional file 1.
Purpose
The ecological-epidemiological model was used to inves-
tigate spatially dynamic bait distribution schemes of oral
mass vaccination of wild boar populations against CSF
with special emphasis on their efficacy in limiting the
spread and survival of the infection.
State variables and scales
The model comprises two major components: a wild
boar demography model considering seasonal reproduc-
tion, dispersal and mortality, and a CSFV model operat-
ing on the emerging boar population. Boar population
density and structure are affected by the disease via leth-
ality and litter size depression (see Additional file 1
Section “Reproduction”).
The crucial model entity is the boar individual, charac-
terised by age in weeks, resulting in the age classes piglet
(< 8 months ± 6 weeks), yearling (< 2 years ± 6 weeks)
and adult. Each host has a location, which also denotes
its home range cell as well as the individual’sf a m i l y
group. Further host state variables are demographic sta-
tus (disperser or non-disperser), epidemiological status
(susceptible, transiently infected or lethally infected with
varying survival times, or immune by surviving the infec-
tion, vaccination or maternal antibodies) and sex.
The model landscape is represented by a grid of 4 km
2
cells, each of which encompass a boar family group’s
core home range [57]. Each grid cell is characterised by
a breeding capacity, denoting habitat quality and thus
the maximum possible number of female boars that can
breed (i.e. population density regulation). Family groups
are formed by females and new ones are established by
seasonal subadult dispersal. Males although associated
as individuals to cells do not disperse explicitly as
females are known to be responsible for the spatial dis-
tribution and establishment of wild boar [47]. The fora-
ging movement of a wild boar group extends beyond
the core area and spatial overlap allowing for e.g. trans-
mission of an infection between families.
Process overview and scheduling
The model proceeds in weekly time steps which repre-
sents the approximate CSF incubation time [58]. Pro-
cesses of each time step are infection, wild boar group
splitting, reproduction, death and ageing, executed in
the given order.
In the first week of each year, mortality probabilities
are assigned stochastically to represent annual fluctua-
tions in boar living conditions. Then every boar is
assigned as breeder or non-breeder, according to the
carrying capacity of its home range cell.
Design concepts
Boar population dynamics emerge from individual beha-
viour, defined by age-dependent seasonal reproduction
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dent dispersal behaviour, all including stochasticity. The
epidemic course emerges from within and between
group virus transmission, boar dispersal and individual
courses of infection. Stochastic lethality of infection and
stochastic infectious periods are modelled explicitly,
since variation in disease outcome between individuals
was known as essential for virus endemicity in host
populations [53].
Details
Initialisation
The heterogeneous model landscape with an extent of
200 km × 50 km is initialised randomly with uniformly
distributed integer breeding capacity values Cij Î {0,
1,...,5}. The average breeding capacity is 2.5 females per
cell, resulting in approximately 20 boars per cell or a
h o s td e n s i t yo f5b o a r sp e rk m
2. Boar density reflects
long-term average values of densely populated Central
European boar habitats [42,59,60] reviewed in [61]. The
landscape thus corresponds to connected boar habitat
without barriers with a population size of about 50 000
individuals, corresponding European wild boar popula-
tions [18,62,63]. The rectangular shape of the landscape
with a high longitudinal, compared to the transversal
extent, was chosen to allow for the analysis of disease
spread and its velocity, while keeping computational
costs tractable.
One boar group is released to each habitat cell. Initial
group size is three times the breeding capacity. Initial
age distributions are taken from the results of a 100-
year model run conducted by Kramer-Schadt et al. [53].
Submodels
In this section we describe the submodels required for
the simulation experiments. More detailed submodel
descriptions are given in the Additional file 1.
Transmission Transmission is modelled stochastically.
Parameters determine the probability of contracting the
infection from an infectious group mate P
(i)
inf and the
probability of contracting the infection from an infec-
tious animal in a neighbouring group P
(e)
inf (3 × 3 neigh-
bourhood) during one week. For each susceptible
animal the probability of becoming infected accumulates
over all infectious animals within the group and in the
neighbourhood:
 i =1− (1 − P
(i)
inf)λi · (1 − P
(e)
inf)

j λj
where li is the number of infected individuals in the
herd and lj is the number of infected individuals in
herds of the 8 neighbouring cells j. The model iterates
over all individuals and stochastically sets each suscepti-
ble individual to infected if a uniformly distributed
random number r drawn from U(0, 1) is smaller than ∏i
of its home cell (Figure 1).
The transmission parameter was reversely fitted [64,65]
to the estimated average disease spread velocity of approx.
8 km per quarter [20] using linear regression (v = -1.5 +
454.5 * P
(i)
inf,R
2 = 0.21). The resulting parameter values
were assigned constant as P
(i)
inf =2 . 0 8· 10−2 within and
P
(e)
inf =2 . 0 8· 10−3 between groups. Resulting spread velo-
cities over the entire parameter space are shown in Figure
2b. The resulting probability of infection, depending on
the number of infectious hosts in the herd and in the
neighbourhood is shown in Figure 1.
Infection might be regularly translocated within the
host population during the dispersal of subadult females.
Disease course The disease course submodel is described
by two parameters: first, individual case mortality (M)
and second the mean infectious period of lethally infected
hosts (μ). Both are used to decide stochastically on the
individual disease course of an infected host i.e. whether
it recovers after a transient infection or when it dies. In
detail, the parameter individual case mortality (M)i s
defined as the Bernoulli probability that decides whether
the infection of an individual host is lethal (with probabil-
ity M) or runs transient (1-M). M applies unchanged for
yearlings M
(y) = M, is decreased for adults to M
(a) = M
2
and increased for piglets to M(p) =
√
M to represent age-
dependent disease outcomes [66]. Transiently infected
boars are infectious for one week, then protected before
they turn to the immune state three weeks later [58,67].
The infectious period (in weeks) of lethally infected hosts
is drawn from an exponential distribution with mean μ.
Figure 3 shows two examples of the resulting distribution
Figure 1 Probability of infection, depending on the number of
infectious hosts in the herd (solid, P
(i)
inf =2 . 0 8· 10−2) and in
neighbouring herds (dashed, P
(e)
inf =2 . 0 8· 10−3).
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infected hosts. Lethally infected hosts remain infectious
until death.
Vaccination Temporal schedule of vaccination cam-
paigns over each year was equivalent for all simulations
and followed existing protocols [29]: baiting campaigns
are possible in fixed calendar weeks 20, 30 and 40 (end
of May, early August, mid-October). Vaccination starts
after virus release with the first possible campaign
according to the temporal schedule and ends with the
end of the simulation. Spatial application schemes were
experimentally altered and are described in the section
“Simulation experiments”. Bait uptake rates in terms of
the proportion of hosts that receive at least one bait per
campaign were assigned as 33% for adults and yearlings,
and 5% for piglets. Piglet uptake rates were set low to
represent difficulties in the vaccination of juveniles, par-
ticularly those younger than 4 - 5 months [12,29]. Bait
uptake is evaluated independent of the animals’ epide-
miologic or vaccination status. The resulting devolution
of the proportion of immune hosts over time in a sus-
ceptible population is shown in Figure 4 and mimics
respective field observations [18]. Immunity is life-long,
and no booster effect is implemented in the model. Oral
vaccination in wild boar is performed recently with C-
strain filled baits. This modified live vaccine was repeat-
edly demonstrated to provide sterile immunity in all ani-
mals after eating a bait [41,45]. A marker vaccine which
has yet been used experimentally for oral vaccination in
the field has equivalent protective characteristics [51].
Figure 2 Isoclines of (A) mean effective infectious period Tinf [weeks], corresponding to parameter combinations M × μ and averaged
over all infected animals. (B) Disease spread velocity [km/quarter].
Figure 3 Realisation of infectious periods over transiently and
lethally infected hosts for M =0 .2, μ = 8 weeks (black) and M =
0.8, μ = 2 weeks (grey).
Figure 4 Time series of proportion of immune hosts due to
oral mass vaccination (total and for age classes). Vertical grey
lines denote dates of baiting campaigns.
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Parameters
For parameter values and sources of submodels
described in this document, see Table 1. For the com-
plete list of parameters, see Additional file 1.
Independent variables
There are two independent variables in our analysis.
Lethality of infection is defined by individual case mor-
tality parameter M, and life-expectancy of lethally
infected hosts is specified by the parameter μ. All simu-
lation experiments were performed for M Î {0.0,
0.1,...,1.0} and μ Î {1, 2,...,10} to cover a wide range, no
matter whether the extremes are biologically meaning-
ful. The range covers lethality from 0 - 100% and mean
infectious periods after lethal infection as long as 10
weeks. With that, we recognize the reported heterogene-
ity in these two parameters as measured in the field
[68-70].
The individual disease courses were scaled up to the
whole population to measure the effective mean infec-
tious period Tinf. The resulting isoclines of Tinf are com-
prised in Figure 2a.
Simulation experiments
Four spatial vaccination schemes (Figure 5), and a non-
vaccination reference were applied. The vaccination
schemes were motivated by different level of accuracy in
following the actually infected area:
0. “No vaccination": reference with no baiting at all.
1. “Complete vaccination": baiting is applied to the
entire landscape (Figure 5a).
2. “Actually infected area vaccination": baiting is
applied on all habitat cells that are infected in the week
of the recent campaign (Figure 5b).
3. “Ever infected area vaccination": baiting is applied
on all habitat cells that have been infected in the given
model run (or recent outbreak, Figure 5c). The strategy
is comparable to recent baiting strategies of successive
vaccination zone extending with disease spread.
4. “Buffered vaccination": baiting is applied on all habi-
tat cells that are infected in the week of the campaign
and a buffer of 32 km around them (Figure 5d). The
buffer radius of 32 km is motivated by the saturation of
the proportion of immune hosts after three campaigns,
i.e. one year (Figure 4) and the spreading velocity of the
epidemic wave of 8 km per quarter, i.e. 32 km per year.
For each vaccination scheme and each M × μ combi-
nation 120 model runs were conducted to achieve a
Table 1 Parameters of the submodels.
Symbol Description Value Source/details
Ttrans Infectious period of transiently infected hosts 1 week [58,67]
P
(i)
inf
Infection probability within/between herds 2.08·10
-2 Reversely fitted to the estimated disease spread velocity of approx.
8 km per quarter [20]
P
(e)
inf
2.08·10
-3
M Case mortality (subadults, see section “Disease course”) (0.0, 0.1, ...,
1.0)
μ Expectation value of the exponential distribution of life
expectancy of lethally infected hosts
(1, 2, ..., 10)
weeks
u
(a) Bait uptake rates adults/yearlings/piglets 0.33 Piglet uptake rates low to represent difficulties in vaccination of
juveniles, younger than 4-5 months [12,60].
u
(y) 0.33
u
(p) 0.05
For the complete list of parameters see Additional file 1.
Figure 5 Schematic diagram of spatial vaccination strategies
with infected area (solid outlines), baiting zone (grey fill), virus
release point (cross) and disease spread direction (arrows). The
circular pattern of infected areas is idealized from more distorted
model outcomes.
Lange et al. Veterinary Research 2012, 43:37
http://www.veterinaryresearch.org/content/43/1/37
Page 5 of 12minimum precision of ± 9% with 95% confidence for
proportions, resulting in 13 200 runs per scheme.
Simulations were performed for 20 years or until host
or virus became extinct. In detail, the virus was released
into the boar population in a random week of the sixth
year by infection of one randomly selected boar indivi-
dual and then simulations continued up to maximum
further 14 years.
Dependent variables
The simulation output focused on two dependent vari-
ables: (1) the extent of the outbreak as measured by the
maximum distance from the release point, and (2) the
risk of endemicity as measured by the probability of
virus circulation after 10 years.
Maximum virus distance from the release point Dmax
was recorded as a measure of disease spread. The aver-
age maximum distance from a randomly selected release
point was about 155 km and is defined by the most dis-
tant corner of the landscape. In detail, for a landscape
of 200 km × 50 km, average maximum edge distances
are 150 km and 37.5 km, resulting in an average possi-
b l ed i s t a n c eo f

(150 km)
2 + (37.5 km)
2 = 154.6 km
if spread always covers the full landscape.
Virus persistence was measured in weeks since virus
release. Individual runs were labelled endemic if the
virus is present after 10 years and non-endemic for ear-
lier virus fade-out. The proportion is then described by
the dependent variable Pend measuring probability of
endemicity from 120 repetitions of a simulation
scenario.
Analysis
Data was analysed by applying contour plots of response
variables using M and μ as X resp. Y axis. To identify
the parameter scopes of the different effects of the
schemes tested, differences to the reference scenario
were calculated.
Analysis was performed using GNU R 2.9.2 (R Core
Development Team); plots were created with Sigma-
Plot
® 10.0 (Systat Software Inc.).
Results
Reference scenarios
Before applying spatially structured vaccination effort,
the model output was considered for the two reference
scenarios: no vaccination (scenario 0) and complete area
vaccination (scenario 1). The scenarios represent the
extremes of possible vaccination effort. The model out-
put was used to determine evaluation criteria for the
two independent variables: Dmax and Pend.F i g u r e6
shows the complete output data of all parameter combi-
nations for non-vaccination (Figure 6a) and complete
area vaccination scenario (Figure 6b), and the difference
between the values of both scenarios, i.e. the effect of
vaccination (Figure 6c).
Without vaccination the majority of parameter combi-
nations revealed a high spreading potential, Dmax,o ft h e
infection (Figure 6a1). Dmax was limited only for very
low case mortality or short survival times of lethally
infected hosts (bottom or left in Figure 6a1). The nega-
tive values in Figure 6c1 indicate for which parameter
combinations complete area vaccination shortened Dmax.
Maximum reduction of Dmax by vaccination (Figure 6c1)
was found for parameter combinations of M and μ in a
bow shaped central area that overlays those between the
isoclines for Tinf =2f r o mb e l o wa n dTinf =6a b o v ei n
Figure 2a. In the remaining parameter combinations,
vaccination had a limited but negative, i.e. desired,
impact on Dmax.
Turning to the probability of endemicity, Figure 6a2
revealed a cup-shaped central area where the infection
became endemic after passing through the population.
Here, the parameters comprise intermediate case mor-
tality values M together with intermediate to long infec-
tious periods of lethally infected hosts μ. For all other
parameter combinations the probability of endemicity
was nearly zero (Figure 6a2, right, bottom, left). This is
reasonable as either maximum case mortalities M cause
strong population thinning behind the epidemic front or
minimum case mortality and very short infectious peri-
ods μ exclude bridging of local deficits of susceptible
hosts due to the short average effective infectious period
Tinf. Complete area vaccination removed the cup-shape
picture of likely endemicity (Figure 6b2). Vaccination
decreased Pend for M < 0.6 and intermediate to long μ
(Figure 6c2). For the same range of μ but maximum
case mortality M, vaccination increased Pend.I fi n f e c -
tious period of lethally infected hosts μ was shorter than
3w e e k sPend already was zero and hence vaccination
could not have any effect.
Structured vaccination schemes
Next, the three alternative spatial vaccination schemes
were considered with regard to the resulting changes in
the model output measures Pend and Dmax.
Buffered vaccination (scenario 4) had the strongest
impact on both Dmax and Pend. Noteworthy, the effect
was almost identical to that of the complete area vacci-
nation (cf. Figure 6c1 and 6c2 with Figure 7a1 and 7a2).
The impact of vaccinating the ever infected area (sce-
nario 3; Figure 7b1 and 7b2) was found to be marginal
in limiting spatial spread. However, the resulting
changes in probability of endemicity roughly coincided
with buffered vaccination but with an overall reduction
in the effect strength (positive and negative change;
Figure 7b2).
Lange et al. Veterinary Research 2012, 43:37
http://www.veterinaryresearch.org/content/43/1/37
Page 6 of 12The impact of vaccinating the actually infected area
(scenario 2; Figure 7c1 and 7c2) was found to be mar-
ginal both with regard to spatial spread and endemicity,
only extreme case mortality M slightly increased the
probability of endemicity (Figure 7c2, top right).
Discussion
The presented simulation study provides understanding
of how vaccination may impact the spread and mainte-
nance of an infection in wild boar populations under dif-
ferent viral constraints [29]. The course of a potential
outbreak was represented by an established model of
Classical Swine Fever (CSF) in wild boar populations
[53]. Therein, alternative spatial application schemes of
oral mass vaccination were implemented. The compara-
tive evaluation of alternatives was focused on two output
quantities: (1) the extent of the outbreak was measured
by the maximum distance from the release point, and (2)
the risk of endemicity was measured by the probability of
virus circulation after 10 years. The first measure is
essential for planning the extent of restriction zones for
the pig production sector according to existing disease
legislation (EU Council Directive 80/217/EEC [71]). The
second measure prescribes whether spatially restricted
host populations can maintain the infection and, hence,
translates into the necessity of disease control within an
infected population [29,41,44,72-74]. Indeed, following
the epidemic phase of an outbreak, either recurrent out-
breaks have to occur inside parts of the area that already
had been affected ("endemic phase” according to [29]), or
the infection will fade out after spreading trough the
population. The first defines endemicity as used in our
analysis. The latter, although leading only to a transient
infection of the host population, often also is referred to
as “long” persistence because depending on the size of
the connected and populated wild boar area, the epi-
demic phase of an outbreak might take a long time till
fade out. For example, with a simulation area of 200 km
Figure 6 (A) No vaccination, (B) complete vaccination, (C) pointwise difference between B and A. (A1, B1, C1) Median of the maximum
achieved distance of the virus from the release point Dmax without vaccination, with vaccination, and the amount of change between both. (A2,
B2, C2) probability of virus endemicity Pend without vaccination, with vaccination and the amount of change between both. All are plotted vs.
case mortality M and mean infectious period of lethally infected hosts μ.
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annum [20] an infection without potential to become
endemic might still be present for 3-6 years depending
on the place of introduction. Therefore, instead of refer-
ring to infections “persisting for a long time” in a popula-
tion, we used “probability of endemicity” to describe
possible maintenance of the infection after it had spread
through the population.
Effectiveness of population vaccination is paralleled to
the reduction in the number of secondary cases pro-
duced by e.g. an infected wild boar group [75,76]. The
number depends on the probability of transmission and
the average infectious period of infected individuals [77].
Under different viral constraints the latter might be
highly variable between individual cases or different
virus strains. For example, different experimental and
field studies of CSFV exhibited a variety of outcome
with regards to the lethality of individual infections
(represented in the model by the parameter M)a n dt h e
variability in the survival time of lethally infected hosts
(from acute to rather chronic infections; represented by
the parameter μ in the model) [29]. To cope with this
uncertainty, the simulation results were produced by
systematically sampling over the possible values of the
two parameters that define individual disease courses.
Simulations in the same wild boar population but
assuming different viral constraints (Figure 6a2), sub-
jected the full range from fade out (e.g. highly virulent
strain CSFV/1.1/dp/CSF0382/XXXX/Koslov [78]) to
endemicity (e.g. moderately virulent strain CSFV/2.3/
wb/CSF1045/2009/Roesrath [78]) to the same vaccina-
tion schemes enabling most general comparison of
effectiveness. Moreover, the results of the comparative
evaluation were tested for their sensitivity to qualitative
alteration of transmission probability (see Additional file
2) but were regained in full.
Figure 7 Effect of strategies (A) buffered, (B) ever infected area and (C) actually infected area vaccination.T o pr o w :c h a n g e si n
maximum virus spread distance Dmax, bottom row: changes in probability of virus endemicity Pend; plotted vs. case mortality M and mean
infectious period of lethally infected hosts μ. Parameter combinations with negative difference reflect a positive impact of vaccination, i.e.
reduced spreading distance or lowered probability of endemicity, while positive differences indicate a worse outcome of the vaccination
alternative compared to the non-vaccination reference.
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Compared to the simulations without vaccination (Figure
6a) the performance of vaccination was overviewed by the
reduction of Pend and Dmax for the different viral con-
straints (Figure 6c1 + 2). The results showed that maxi-
mum reduction of spatial spread of the infection was
achieved for viral constraints that resulted in an effective
average infectious period Tinf between 2 and 6 weeks
(Figure 2a). Thereof maximum reduction in the probability
of endemicity was achieved only for moderate case mortal-
ities (M < 60%) combined with sufficiently long infectious
periods of lethally infected hosts (μ > 3 weeks). Interest-
ingly recent outbreaks are characterised by moderate leth-
ality of less than 50% and few acute courses i.e. few of the
lethally infected animals dying within less than four weeks
[41,44,58,62]. Thus, with the recent CSFV strains in wild
boar (e.g. moderately virulent strain CSFV/2.3/wb/
CSF1045/2009/Roesrath [78]) the treatment of the total
wild boar population - although impractical - is expected
to prevent spatial spread and the endemicity of the
infection.
If high case mortality and long mean infectious periods
of lethally infected animals were assumed, vaccination
had no effect on the spatial spread but induced a prolon-
gation of virus circulation. This is reasonable as without
vaccination the decline of the population density behind
the epidemic front due to high lethality already favours
fade-out although spatial spread covered the whole area
(Figure 6a1 + 2). Indeed, the initial average density of the
simulated population was 5 hosts per km
2, lethality of
80% left an approximate population density of 1 host per
km
2 behind the epidemic front. Guberti et al. [26] esti-
mated the threshold for CSFV spread as 1 host per km
2
making self-eradication a consistent outcome. Vaccina-
tion now prevented the collapse of the host population.
As a consequence, the infection became endemic when
the mean life expectancy of lethally infected hosts was set
sufficiently long (i.e. μ above 4 weeks).
With CSFV such highly lethal infections are expected to
coincide with rather short mean life expectancies of
infected hosts (e.g. highly virulent strain CSFV/1.1/dp/
CSF0382/XXXX/Koslov [78]). Therefore, such a negative
impact of vaccination is less likely with CSFV control.
More general, however, our results suggest that vaccina-
tion planning should be performed with caution if an out-
break is reported to kill the majority of infected animals: If
the mean infectious period of the disease is very short, the
outbreak is expected to be self-limiting in the population;
if not, vaccination might even create endemicity.
Alternative baiting strategies - feasible expectations
Astonishingly, the buffered vaccination approach backed
up the efficacy of complete area vaccination with regard to
both criteria “prevention of disease spread” (Figure 7a1
and Figure 6c1) and “eradication” (Figure 7a2 and Figure
6c2). Baiting one year ahead of disease spread sufficiently
mimicked the large proactive component of complete area
vaccination. The backward component of the buffered
strategy shows parallels with recent control proposals [29]
that recommend repeated vaccination for at least one year
after the last case detection in a local area.
The key assets in the strategy are the temporal raise of
population immunity and the spreading distance of
CSFV during one year:
Considering the devolution of population immunity by
number of campaigns in a susceptible population
(Figure 4), the assumed bait uptake led to saturation of
population immunity after about 3 campaigns (i.e.
1 year of regular vaccination schedule). This dynamics is
comparable to the dynamics observed in areas where
oral vaccination was practiced before the reporting of
CSF infections [18].
In the simulation model, the known spreading velocity
value of 8 km per annual quarter [20] was scaled to
transmission between a sufficient number of wild boar
groups. If, however, the spreading distance of 32 km per
annum is less general, e.g. an infection spreads differently
fast in other eco-regions, then the results of our simula-
tions are robust and will be repeated if the width of the
buffer is aligned to the alternatively reported distance
value. The success of this strategy might be favoured by
the regular boar habitat structure in the model. Whether
alteration of spreading velocity in structured landscapes
of boar habitat requires adjustment of buffer width needs
further detailed examination [79-81].
Baiting of areas that were ever infected during the out-
break is comparable to recent baiting strategies of succes-
sive extension of vaccination zones in accordance with
disease spread. The strategy has a strong backward com-
ponent but no proactive component. Hence, it is reason-
able that this strategy cannot decrease spatial disease
spread. With continued, uncontrolled spread of the infec-
tion through the wild boar area the strategy successively
converged to the complete area design along with an
increasing proportion of the landscape affected. Virus
eradication can thus be expected to take place in late-
stage disease control, while annual baiting costs increase
with ongoing disease presence. More relevant, however,
is the lacking potential to prevent disease spread i.e. the
growth of the infected area.
Baiting of actually infected habitat areas (Figure 7c)
was revealed to be completely ineffective. This appears
reasonable as both the proactive and the backward com-
ponent of the complete area baiting are no longer rea-
lised. Although the approach is often taken to be most
cost effective [82], this judgement usually ignores total
effort, which accumulates quickly if no eradication can
be achieved.
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Page 9 of 12At first glance, these findings contradict vaccination suc-
cesses reported from the field with ever infected area vacci-
nation [18]. However, in this particular area the vaccination
protocol changed during the control program [83] because
the unavailable marker property of the applied vaccine lim-
ited the follow up investigation. Vaccination started with a
wide buffer around the infected area (compare Figures 26a
and 27a in von Rüden [83]), but later protocols foresee
only the newly infected area to be added to the baiting area
(ever infected area vaccination scenario) which did not
actually happen. Following our findings, the positive effect
of the “buffer” included in the initial campaigns already
might have caused the observed success.
The concept of vaccinating the infected area or an addi-
tional buffer around it obviously depends on the monitor-
ing of the infected area [60]. If monitoring relies on
serological investigations (e.g. CSF), oral mass vaccination
will hamper the applicability of the strategies if no marker
vaccines are available for oral application which allow dif-
ferentiation of vaccinated from infected animals. For vacci-
nation against CSFV infections in wild boar efforts are on
the way to substitute the recent vaccine by an orally
applicable marker version with the same protective char-
acteristics. The vaccine already was tested experimentally
in the field and thus motivated the systematic evaluation
of possible new spatial vaccination schemes that make use
of the dynamic actual infected area (see, e.g. [51,84,85]).
Additional material
Additional file 1: ODD Model Documentation.
Additional file 2: Sensitivity analysis.
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